UEMR Versus HSP in the Treatment of Pedunculated Colorectal Polyps Less Than 10mm in Size
NCT ID: NCT06996522
Last Updated: 2025-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
338 participants
INTERVENTIONAL
2025-06-01
2027-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
UEMR vs. CEMR for Diminutive Non-pedunculated Colorectal Polyps
NCT03833492
UEMR for Medium-sized Pedunculated Colon Polyps
NCT04837690
Underwater Versus Conventional Endoscopic Mucosal Resection in the Treatment of Non-pedunculated Colorectal Polyps
NCT05825664
Underwater Endoscopic Mucosal Resection Versus Metal Clips With Hot Snare Polypectomy for Resection of Big Pedunculated Colorectal Polyps
NCT06097637
Submucosal Injection EMR vs. Underwater EMR for Colorectal Polyps
NCT01712048
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Randomize patients with pedunculated colorectal polyps less than 10mm in size into 2 interventional groups based on Random function of Statistical Package for the Social Sciences (SPSS) 20.0, including (1) Group 1: Underwater endoscopic mucosal resection (UEMR) and (2) Group 2: Hot snare polypectomy (HSP).
3. Collecting variables which consist of primary and secodary outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
UEMR in treating Pedunculated colorectal polyps less than 10mm in size
The UEMR procedure included the following: (1) Water infusion to distend the intestinal lumen; (2) entrapment of the mucosal protrusion with a snare; and (3) resection using electrocautery
underwater endoscopic mucosal resection
The Pedunculated colorectal polyps less than 10mm in size in this group will be treated by UEMR
HSP in treating Pedunculated colorectal polyps less than 10mm in size
The HSP procedure included the following: (1) entrapment and resection of the polyp with a snare with electrocautery.
Hot snare polypectomy
The Pedunculated colorectal polyps less than 10mm in size in this group will be treated by HSP
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
underwater endoscopic mucosal resection
The Pedunculated colorectal polyps less than 10mm in size in this group will be treated by UEMR
Hot snare polypectomy
The Pedunculated colorectal polyps less than 10mm in size in this group will be treated by HSP
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pedunculated colorectal polyps less than 10mm in size in screening, surveillance or therapeutic colonoscopy
* 0-Isp or 0-Ip according to Paris classification
* Patients must sign an informed consent form prior to registration in study
Exclusion Criteria
* Suspected malignancy
* History of inflammatory bowel disease or colorectal resection
* Familial adenomatous polyposis or Lynch syndrome
* Patients taking anticoagulant and antiplatelet agents before the examination
* Inadequate bowel preparation, defined as a Boston Bowel Preparation Scale score \< 6
* ASA \>=3
* Pregnancy or breastfeeding
* Severe comorbid disease involving the heart, lungs, liver, or kidneys.
* Concurrent serious conditions, including other active malignancies or severe infectious diseases
35 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhijun Bao
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhiyu Dong, M.D.
Role: STUDY_DIRECTOR
Huadong Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Huadong hospital affiliated to Fudan university
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025K132
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.